24 Zoledronic acid (ZOL) as add-on therapy in patients with...

24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)

G. von Minckwitz, M.D. Zahm, H. Eidtmann, H. Tesch, A. du Bois, K. Schwedler, J. Hilfrich, C. Jackisch, K. Mehta, B. Gerber
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70055-0
File:
PDF, 47 KB
english, 2010
Conversion to is in progress
Conversion to is failed